Detalhe da pesquisa
1.
Antagonism of metabotropic glutamate receptor type 5 prevents levodopa-induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence.
J Neurosci Res
; 102(3): e25302, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38515319
2.
α-Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid-Binding Property.
Mov Disord
; 37(10): 2075-2085, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894540
3.
Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.
Proc Natl Acad Sci U S A
; 116(41): 20689-20699, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31548400
4.
Mutations in CHCHD2 cause α-synuclein aggregation.
Hum Mol Genet
; 28(23): 3895-3911, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31600778
5.
Variants in saposin D domain of prosaposin gene linked to Parkinson's disease.
Brain
; 143(4): 1190-1205, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201884
6.
Preserved proteinase K-resistant core after amplification of alpha-synuclein aggregates: Implication to disease-related structural study.
Biochem Biophys Res Commun
; 522(3): 655-661, 2020 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31785806
7.
Shared Metabolic Profile of Caffeine in Parkinsonian Disorders.
Mov Disord
; 35(8): 1438-1447, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32357260
8.
Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
Mov Disord
; 33(9): 1488-1492, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756366
9.
Gray Matter Abnormalities in Idiopathic Parkinson's Disease: Evaluation by Diffusional Kurtosis Imaging and Neurite Orientation Dispersion and Density Imaging.
Hum Brain Mapp
; 38(7): 3704-3722, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470878
10.
Neuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.
J Neural Transm (Vienna)
; 124(4): 407-415, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28160151
11.
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies.
J Neurol Neurosurg Psychiatry
; 87(3): 295-301, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25795009
12.
Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease.
Eur Radiol
; 26(8): 2567-77, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26515546
13.
[Mechanisms Underlying the Propagation of α-Synuclein Seeds Derived from the Blood of Patients with α-Synucleinopathies].
Brain Nerve
; 76(6): 767-772, 2024 Jun.
Artigo
em Japonês
| MEDLINE | ID: mdl-38853507
14.
Generation of hiPSCs (JUCGRMi003-A) from a patient with Parkinson's disease with PARK2 mutation.
Stem Cell Res
; 76: 103323, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38309147
15.
α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders.
J Mov Disord
; 17(2): 127-137, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589016
16.
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.
Mov Disord Clin Pract
; 11(4): 352-362, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264844
17.
Aging, aortic arch calcification, and multiple brain infarcts are associated with aortogenic brain embolism.
Cerebrovasc Dis
; 35(3): 282-90, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23594963
18.
Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Nat Med
; 29(6): 1448-1455, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248302
19.
Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission.
Commun Biol
; 5(1): 636, 2022 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768587
20.
Comorbid alpha synucleinopathies in idiopathic normal pressure hydrocephalus.
J Neurol
; 269(4): 2022-2029, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468800